TGFB1 and gastric cancer: These models target key signaling pathways that are frequently dysregulated in human gastric cancer, including nuclear receptor signaling, cytokine/STAT pathways, TGF-β signaling, innate immunity, and Wnt signaling, providing mechanistic insights into the oncogenic processes driving human disease.